Search

Author/Creator Collichio, Frances

1. 433 Talimogene laherparepvec (T-VEC) in combination with ipilimumab (IPI) versus IPI alone for advanced melanoma: 4-year interim analysis of a randomized, open-label, phase 2 trial. (10th December 2020)

Authors:
Puzanov, Igor; Chesney, Jason; Collichio, Frances; Singh, Parminder; Milhem, Mohammed; Glaspy, John; Hamid, Omid; Ross, Merrick; Friedlander, Philip; Garbe, Claus; Logan, Theodore; Hauschild, Axel; Lebbe, Celeste; Yi, Min; Snyder, Wendy; Mehnert, Janice
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A263
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Final analyses of OPTiM: a randomized phase III trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in unresectable stage III–IV melanoma. Issue 1 (6th June 2019)

Authors:
Andtbacka, Robert H. I.; Collichio, Frances; Harrington, Kevin J.; Middleton, Mark R.; Downey, Gerald; Ӧhrling, Katarina; Kaufman, Howard L.
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform. Issue 1 (January 2022)

Authors:
Martin, Richard L.; Grant, Michael J.; Kimani, Stephen; Midha, Shonali; May, Jori; Patell, Rushad; Collier, Emily; Furfaro, David; Bodine, Charles; Reap, Leo; Shah, Nikesh; DeLaune, Jess; Brusca, Samuel; Olazagasti, Coral; Goyal, Shreya; Rubinstein, Samuel; Hakim, Nausheen; Qin, Shuai; Browning, ...
Journal:
JCO oncology practice
Issue:
Volume 18:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗